Dechra announces sale of the Avishield® poultry vaccines portfolio to Vaxxinova
The Netherlands, June 17, 2025 — The Avishield portfolio currently consists of eight products manufactured, marketed and sold by Dechra into 29 countries. In addition, the Dechra poultry vaccine research and development (R&D) team of 24 people based in Zagreb, Croatia, and corresponding pipeline of potential future products, will also transfer to Vaxxinova upon completion, […]
Read more →
Warren Crosby Appointed as Industrial Director at Vaxxinova Italy
Chignolo Po, Italy, June 13, 2025 — We are pleased to announce that Warren Crosby has joined Vaxxinova as Industrial Director at our Chignolo Po production site in Italy, effective June 3rd, 2025. Warren brings a wealth of experience in Animal Health manufacturing, particularly in the field of poultry vaccines. His career spans over two decades, with key leadership roles at Merial and Boehringer Ingelheim, where he managed production […]
Read more →
Historic Milestone Achieved: USDA Approves First-Ever Import of Live Vaccine into the United States.
Willmar, Minnesota — Vaxxinova US proudly announces a groundbreaking development for animal health and the poultry industry. The United States Department of Agriculture (USDA) has approved importation of a live Avian metapneumovirus vaccine, Vaxxon® SHS, into the U.S. market. This unprecedented approval marks a significant milestone in the fight against Avian metapneumovirus (aMPV). Vaxxon® SHS […]
Read more →
Vaxxinova®
Vaxxinova is committed to disease prevention in production animals. We aim to provide a complete set of vaccines and diagnostic services, supported by our global R&D network. Vaxxinova believes in ‘business without borders’ and long term partnerships with veterinarians and animal health professionals. We work together in disease prevention and livestock performance improvement programs. Our technical teams can advise you on our products and services.